Patents by Inventor Raymond PAL PAGLIARINI

Raymond PAL PAGLIARINI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10479997
    Abstract: The invention provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating subjects having TMPRSS2:ERG positive prostate cancer, which we show is amenable to therapeutic treatment with a PRMT5 inhibitor. Kits, methods of screening for candidate PRMT5 inhibitors, and associated methods of treatment are also provided.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: November 19, 2019
    Assignee: NOVARTIS AG
    Inventors: Zineb Mounir, Raymond Pal Pagliarini
  • Publication number: 20170283807
    Abstract: The invention provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating subjects having TMPRSS2:ERG positive prostate cancer, which we show is amenable to therapeutic treatment with a PRMT5 inhibitor. Kits, methods of screening for candidate PRMT5 inhibitors, and associated methods of treatment are also provided.
    Type: Application
    Filed: December 1, 2015
    Publication date: October 5, 2017
    Applicant: Novartis AG
    Inventors: Zineb MOUNIR, Raymond PAL PAGLIARINI